wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q42573450-7A4AA7EF-A93A-4EA2-8B94-EE69589D46D6
Q42573450-7A4AA7EF-A93A-4EA2-8B94-EE69589D46D6
BestRank
Statement
http://www.wikidata.org/entity/statement/Q42573450-7A4AA7EF-A93A-4EA2-8B94-EE69589D46D6
The emerging low-dose therapy for advanced cancers.
P2860
Q42573450-7A4AA7EF-A93A-4EA2-8B94-EE69589D46D6
BestRank
Statement
http://www.wikidata.org/entity/statement/Q42573450-7A4AA7EF-A93A-4EA2-8B94-EE69589D46D6
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
1b514022682e3e81d61ea4bc1e1d589af4bb3a89
P2860
Phase II clinical trial results involving treatment with low-dose daily oral cyclophosphamide, weekly vinblastine, and rofecoxib in patients with advanced solid tumors.